NCT03631498

Brief Summary

Smoking is a major environmental risk factor associated with common forms of human chronic periodontitis. The aim of the present study was to evaluate apoptotic tissue alterations and tissue destruction in smoker and non-smoker chronic periodontitis patients and healthy individuals. The investigators of the study suggest that smoking decrease tissue quality and increase inflammation level in gingival tissues in both healthy individuals and periodontitis patients. One possible mechanism for this is suggested to be increased apoptosis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2017

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 10, 2018

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

August 13, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 15, 2018

Completed
Last Updated

August 16, 2018

Status Verified

August 1, 2018

Enrollment Period

1 year

First QC Date

August 13, 2018

Last Update Submit

August 15, 2018

Conditions

Keywords

smokinghypoxiaapoptosischronic periodontitis

Outcome Measures

Primary Outcomes (1)

  • Fibroblast and total inflammatory cell counts

    Fibroblast and total inflammatory cell counts in the groups were determined in a standardized 1000 micrometer square area with histomorphometric evaluation.

    Biopsies were obtained a day after initial examinations, histological analysis were performed 2 weeks after.

Secondary Outcomes (2)

  • Apoptotic markers

    Biopsies were obtained a day after initial examinations, histological analysis were performed 2 weeks after

  • Hypoxia and tissue destruction markers

    Biopsies were obtained a day after initial examinations, histological analysis were performed 2 weeks after

Study Arms (4)

Healthy individuals

Gingival biopsies of healthy individuals who were never-smokers and had no systemic or oral disease or condition.

periodontitis patients

Gingival biopsies of periodontitis patients who were never-smokers and had no systemic disease or condition.

Healthy smokers

Gingival biopsies of healthy individuals who were smokers but no systemic or oral disease or condition.

Smokers with periodontitis

Gingival biopsies of periodontitis patients who were smokers but no systemic disease or condition.

Eligibility Criteria

Age30 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Healthy individuals who were either smokers or non-smokers, chronic periodontitis patients who were either smokers or non-smokers older than 30 years old and younger than 50 years old were enrolled. The age was specifically chosen because aging changes periodontal and gingival tissues independently of other variables. Any possible factor which might alter connective tissue metabolism were excluded.

You may qualify if:

  • Age range from 30 to 45,
  • the existence of at least 20 functioning teeth,
  • systemical health,
  • no antibiotic use within 6 months,
  • no periodontal therapy within 6 months,
  • no pregnancy or lactation,
  • no drug use, in addition; for the smokers existence of the smoking condition for at least five years.

You may not qualify if:

  • Patients younger than 30 older than 50 years old,
  • the absence of occlusion,
  • drug use,
  • pregnancy/lactation,
  • previous antibiotic use,
  • previous periodontal therapy,
  • the existence of any systemical disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gaziosmanpasa University Faculty of Dentistry

Tokat Province, 60100, Turkey (Türkiye)

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Gingival tissue biopsy samples

MeSH Terms

Conditions

SmokingChronic PeriodontitisHypoxia

Condition Hierarchy (Ancestors)

BehaviorPeriodontitisPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms, RespiratorySigns and Symptoms

Study Officials

  • HATİCE BALCI YÜCE, PhD

    Gaziosmanpasa University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

August 13, 2018

First Posted

August 15, 2018

Study Start

January 10, 2017

Primary Completion

January 10, 2018

Study Completion

April 10, 2018

Last Updated

August 16, 2018

Record last verified: 2018-08

Locations